renal pathology 2
TRANSCRIPT
-
8/14/2019 Renal Pathology 2
1/61
GLOMERULAR
DISEASES
-
8/14/2019 Renal Pathology 2
2/61
-
8/14/2019 Renal Pathology 2
3/61
-
8/14/2019 Renal Pathology 2
4/61
Glomerular Syndrome
1. Acute nephritic syndrome
2. Rapidly progressive glomerulonephritis
3. Chronic renal falure
4. Asymptomatic hematuria/proteinuria
-
8/14/2019 Renal Pathology 2
5/61
Nephrotic Syndrome
Manifestations Massive proteinuria
Hypoalbuminemia
Generalized edema
Hyperlipidemia and lipiduria
-
8/14/2019 Renal Pathology 2
6/61
-
8/14/2019 Renal Pathology 2
7/61
Minimal Change Disease
Lipoid nephrosis, Nil disease, Idiopathicnephrotic syndrome
Most common cause of NS in children
Dramatic response to steroids Of unknown cause NSAID, allergic
reactions
May present with acute renal failure Differentiate from focal segmental
glomerulosclerosis
-
8/14/2019 Renal Pathology 2
8/61
Minimal Change Disease
LM: few, if any changes
IF: usually negative; may have mesangialIgM
EM: widespread effacement of podocytefoot processes Villous hypertrophy of podocytes
Absence of deposits
-
8/14/2019 Renal Pathology 2
9/61
-
8/14/2019 Renal Pathology 2
10/61
Focal Segmental
Classifications In association with other known conditions
HIV, heroin, sickle cell disease, massive obesity
As a secondary event reflecting glomerularscarring
As an adaptive response
In certain inherited, congenital forms of NS As a primary disease --- idiopathic
-
8/14/2019 Renal Pathology 2
11/61
-
8/14/2019 Renal Pathology 2
12/61
Failure to respond to steroidsMay have microscopic hematuria,hypertension or renal insufficiencySome develop ESRDRecurrence after transplantation
-
8/14/2019 Renal Pathology 2
13/61
Differ from minimal change disease
They have a higher incidence of hematuria,
reduced GFR and HPN
Their proteinuria is more often nonselective
They respond poorly to steroids
Many progress to CGN
IMF shows deposition of IgM and C3 in
sclerotic segment
-
8/14/2019 Renal Pathology 2
14/61
LM: some glomeruli with segmental sclerosis
(mesangial matrix material, collapse, BM-likematerial) +/- hyalinosis
Focal segmental consolidation of the tuft
with obliteration of the capillary, often withadhesions to Bowmans capsule
Hyalinosis
+/- podocyte hypertrophy
-
8/14/2019 Renal Pathology 2
15/61
IF: usually negative except IgM +/- C3 insclerotic segmentEM: widespread podocyte foot processeffacement
accumulation in collapsed loop of matrix-likematerial
-
8/14/2019 Renal Pathology 2
16/61
-
8/14/2019 Renal Pathology 2
17/61
-
8/14/2019 Renal Pathology 2
18/61
-
8/14/2019 Renal Pathology 2
19/61
Membranous
Can be primary or secondary
Secondary causes Drugs Underlying malignant tumors
SLE
Infections Metabolic disorders
-
8/14/2019 Renal Pathology 2
20/61
Some have asymptomatic proteinuriaNephrotic syndromeSome --- remissionOthers --- ESRDDeposits may be formed by theinteraction of autoantibodies with
podocyte surface antigens
-
8/14/2019 Renal Pathology 2
21/61
LM: normal to extreme diffuse thickening of
the cap wall, foam cells in the interstitium
Spikes
IF: finely granular diffuse cap wall staining--- IgG +/- C3 and others
EM: numerous subepithelial deposits +/-
spikes of GBM betweenCourse: 1/3 progress, 1/3 remit, 1/3proteinuria only
-
8/14/2019 Renal Pathology 2
22/61
-
8/14/2019 Renal Pathology 2
23/61
-
8/14/2019 Renal Pathology 2
24/61
-
8/14/2019 Renal Pathology 2
25/61
Membranoproliferative GN
Can be primary or secondary
Secondary causes Chronic immune-complex disorders
SLE, hepatitis B, hepatitis C, endocarditis, HIV,
schistosomiasis Partial lipoid dystrophy associated with C3NeF
Alpha-1 antitrypsin deficiency
Malignant diseases
CLL, lymphoma, melanoma Hereditary complement deficiency states
-
8/14/2019 Renal Pathology 2
26/61
MPGN types I, II and III
LM: proliferative, mesangial matrix increase,lobulation, tram-tracking, capillary wall thickening
IF: broad cap wall deposits and less often in themesangium --- C3 +/- others
EM:
Type I massive subendothelial deposits +/- mesangialdeposits
Type II large electron-dense deposits inintramembranous portion
Type III subepithelial deposits, segmental GBM
fragmentation
-
8/14/2019 Renal Pathology 2
27/61
Course: progressive (many to renal failure)
DX: low complement, nephrotic/nephritic
-
8/14/2019 Renal Pathology 2
28/61
-
8/14/2019 Renal Pathology 2
29/61
-
8/14/2019 Renal Pathology 2
30/61
-
8/14/2019 Renal Pathology 2
31/61
-
8/14/2019 Renal Pathology 2
32/61
-
8/14/2019 Renal Pathology 2
33/61
IgA Nephropathy (Bergers
Frequent cause of recurrent gross ormicroscopic hematuria
+/- NS or RPGN
Initially considered to be benign
May lead to ESRD Reversible ARF from numerous tubular
casts and tubular injury
-
8/14/2019 Renal Pathology 2
34/61
LM: any glomerular patternIF: intense mesangial granular IgAEM: dense deposits in mesangial
paramesangial areas
-
8/14/2019 Renal Pathology 2
35/61
Pathogenesis: deposition in glomeruli ofabnormal forms of circulating IgAresulting from abnormal glycosylation
IgA binds to mesangial cells Role of alternative complement pathway
No diagnostic serologic test for IgAnephropathy
-
8/14/2019 Renal Pathology 2
36/61
-
8/14/2019 Renal Pathology 2
37/61
-
8/14/2019 Renal Pathology 2
38/61
PoststreptococcalGlomerulone hritis
1-4 weeks after a streptococcal infectionof the pharynx or skin
6-10 yo but may affect any age
Group A beta- hemolytic streptococcitypes 12, 4 and 1
Acute nephritis syndrome: gross
hematuria, edema and hypertension
-
8/14/2019 Renal Pathology 2
39/61
A minority --- severe renal insufficiencyLow C3Glomerular immune deposits represent
Ag-Ab complexes
-
8/14/2019 Renal Pathology 2
40/61
LM: proliferative, exudative (PMNs), +/-
crescentsIF: granular GBM --- IgG +/- C3
EM: subepithelial humps +/- small
subendothelial/mesangial deposits
Course: resolves in vast majority of cases
Dx: ASO up, complement down, nephriticsyndrome, HPN
-
8/14/2019 Renal Pathology 2
41/61
-
8/14/2019 Renal Pathology 2
42/61
-
8/14/2019 Renal Pathology 2
43/61
Nonstreptococcal acute GN
Bacterial, viral and parasitic infections
-
8/14/2019 Renal Pathology 2
44/61
-
8/14/2019 Renal Pathology 2
45/61
Rapidly Progressive GN
Crescentic GN Rapid and progressive loss of renal function
associated with severe oliguria and (if
untreated) death from renal failure withinweeks to months
-
8/14/2019 Renal Pathology 2
46/61
-
8/14/2019 Renal Pathology 2
47/61
LM: over 50% of glomeruli with crescents
IF:1/3 granular (immune complex GN, e.g. SLE, post-infectious GN)
1/3 linear (anti-GBM, e.g. Goodpastures disease)
1/3 no deposits (e.g. PAN, Wegeners, vasculitis)
EM: glomerular deposits anywhere
Course: terrible (progression to ESRD exceptpost-infectious)
-
8/14/2019 Renal Pathology 2
48/61
-
8/14/2019 Renal Pathology 2
49/61
Anti-GBM Disease
Autoantibodies against the NC1 domain ofthe alpha 3 chain of type IV collagen(Goodpasture Ag)
Associated with pulmonary hemorrhage LM: crescentic
IF: strong linear staining along the GBM
-
8/14/2019 Renal Pathology 2
50/61
-
8/14/2019 Renal Pathology 2
51/61
Hereditary Nephritis
Alport syndrome Nephritis accompanied by nerve deafness
and various eye disorders (lens dislocation,
post. Cataracts and corneal dystrophy) Males > females, hematuria
Defective form of BM due to mutations ingenes that encode components of type IV
collagen
-
8/14/2019 Renal Pathology 2
52/61
In 80% x-linked inherritanceIn 15% autosomal recessiveRarely autosomal dominantSkin biopsy (alpha 5)Anti-GBM disease after transplantation
-
8/14/2019 Renal Pathology 2
53/61
LM: segmental proliferation or sclerosis,fetal-like glomeruli, mesangial matrixincrease
EM: irregular foci of thickening or thinningwith splitting and lamination of laminadensa
- mainly thinning in female carriers
-
8/14/2019 Renal Pathology 2
54/61
-
8/14/2019 Renal Pathology 2
55/61
-
8/14/2019 Renal Pathology 2
56/61
Thin Basement Membrane
Benign familial hematuria
Diffuse thinning of the GBM to between150 and 225 nm (normal = 300 to 400 nm)
-
8/14/2019 Renal Pathology 2
57/61
-
8/14/2019 Renal Pathology 2
58/61
Chronic GN
End-stage pool of glomerular diseases
A number of cases arise mysteriously
without antecedent history of any of thewell-recognized forms of early GN
-
8/14/2019 Renal Pathology 2
59/61
-
8/14/2019 Renal Pathology 2
60/61
-
8/14/2019 Renal Pathology 2
61/61